Broad-spectrum coverage that breaks through today’s pathogens
DORIBAX® indicated pathogens for complicated urinary tract infection and complicated intra-abdominal infection
*Complicated urinary tract infections.
† Complicated intra-abdominal infections.
How many patients worldwide have been treated with doripenem from approval through April 2010?
Learn more about the recommended dosing regimen of DORIBAX®.
Please see Indications and Important Safety Information below.